Literature DB >> 15499546

Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission.

Christine M Rousseau1, Ruth W Nduati, Barbra A Richardson, Grace C John-Stewart, Dorothy A Mbori-Ngacha, Joan K Kreiss, Julie Overbaugh.   

Abstract

Understanding how the level of human immunodeficiency virus type 1 (HIV-1)-infected breast milk cells (BMCs) affects HIV transmission via breast-feeding can shed light on the mechanism of infection and aid in establishing effective interventions. The proportion of infected cells to total cells was measured in serial breast milk samples collected from 291 HIV-1-infected women in Nairobi, Kenya, by use of real-time DNA polymerase chain reaction amplification of BMCs. The number of infected BMCs per million cells was associated with levels of cell-free viral RNA in breast milk (R=.144; P=.032), levels of cell-free virus in blood plasma (R=.365; P<.001), and the detection of proviral DNA in cervical and vaginal secretions (P<.001 and P = .030, respectively). The number of infected BMCs per million cells was lower in colostrum or early milk than in mature milk (P<.001). Previous studies demonstrated that the concentration of BMCs varies throughout lactation, and we used these data to transform infected BMCs per million cells to infected BMCs per milliliter. The estimated concentration of infected BMCs per milliliter was higher in colostrum or early milk than in mature milk (P<.001). Each log10 increase in infected BMCs per milliliter was associated with a 3.19-fold-increased risk of transmission (P=.002), after adjustment for cell-free virus in plasma (hazard ratio [HR], 2.09; P=.03) and breast milk (HR, 1.01; P=1.00). This suggests that infected BMCs may play a more important role in transmission of HIV via breast-feeding than does cell-free virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499546      PMCID: PMC3384735          DOI: 10.1086/425076

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

Review 1.  Antiviral activities of lactoferrin.

Authors:  B W van der Strate; L Beljaars; G Molema; M C Harmsen; D K Meijer
Journal:  Antiviral Res       Date:  2001-12       Impact factor: 5.970

2.  Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.

Authors:  Gang Meng; Xiping Wei; Xiaoyun Wu; Marty T Sellers; Julie M Decker; Zina Moldoveanu; Jan M Orenstein; Martin F Graham; John C Kappes; Jiri Mestecky; George M Shaw; Phillip D Smith
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

3.  Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells.

Authors:  H Hocini; P Becquart; H Bouhlal; N Chomont; P Ancuta; M D Kazatchkine; L Bélec
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa.

Authors:  A Coutsoudis; K Pillay; L Kuhn; E Spooner; W Y Tsai; H M Coovadia
Journal:  AIDS       Date:  2001-02-16       Impact factor: 4.177

Review 5.  Chemokines as natural HIV antagonists.

Authors:  Alessia Verani; Paolo Lusso
Journal:  Curr Mol Med       Date:  2002-12       Impact factor: 2.222

6.  Sequence variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes.

Authors:  Cara Carthel Burns; Lisa M Gleason; Afsaneh Mozaffarian; Cristina Giachetti; Jean K Carr; Julie Overbaugh
Journal:  AIDS Res Hum Retroviruses       Date:  2002-09-20       Impact factor: 2.205

7.  Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection.

Authors:  S Lagaye; M Derrien; E Menu; C Coïto; E Tresoldi; P Mauclère; G Scarlatti; G Chaouat; F Barré-Sinoussi; M Bomsel
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

9.  Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease.

Authors:  Christine M Rousseau; Ruth W Nduati; Barbra A Richardson; Matthew S Steele; Grace C John-Stewart; Dorothy A Mbori-Ngacha; Joan K Kreiss; Julie Overbaugh
Journal:  J Infect Dis       Date:  2003-02-18       Impact factor: 5.226

Review 10.  Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management.

Authors:  E N Janoff; P D Smith
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

View more
  93 in total

1.  Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.

Authors:  Alison L Drake; Alison C Roxby; Francisca Ongecha-Owuor; James Kiarie; Grace John-Stewart; Anna Wald; Barbra A Richardson; Jane Hitti; Julie Overbaugh; Sandra Emery; Carey Farquhar
Journal:  J Infect Dis       Date:  2011-12-06       Impact factor: 5.226

2.  Increased levels of HIV-1-infected cells in endocervical secretions after the luteinizing hormone surge.

Authors:  Sarah Benki; Sara B Mostad; Barbra A Richardson; Kishorchandra Mandaliya; Joan K Kreiss; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2008-04-15       Impact factor: 3.731

3.  Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi.

Authors:  Charles van der Horst; Charles Chasela; Yusuf Ahmed; Irving Hoffman; Mina Hosseinipour; Rodney Knight; Susan Fiscus; Michael Hudgens; Peter Kazembe; Margaret Bentley; Linda Adair; Ellen Piwoz; Francis Martinson; Ann Duerr; Athena Kourtis; A Edde Loeliger; Beth Tohill; Sascha Ellington; Denise Jamieson
Journal:  Contemp Clin Trials       Date:  2008-09-07       Impact factor: 2.226

4.  HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.

Authors:  Genevieve G Fouda; Nicole L Yates; Justin Pollara; Xiaoying Shen; Glenn R Overman; Tatenda Mahlokozera; Andrew B Wilks; Helen H Kang; Jesus F Salazar-Gonzalez; Maria G Salazar; Linda Kalilani; Steve R Meshnick; Beatrice H Hahn; George M Shaw; Rachel V Lovingood; Thomas N Denny; Barton Haynes; Norman L Letvin; Guido Ferrari; David C Montefiori; Georgia D Tomaras; Sallie R Permar
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

5.  Mother-to-child transmission of HIV: a global perspective.

Authors:  Katherine Luzuriaga
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

Review 6.  The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies.

Authors:  Kristina Abel
Journal:  Curr HIV Res       Date:  2009-01       Impact factor: 1.581

7.  Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding.

Authors:  Ivona Pandrea; Richard Onanga; Sandrine Souquiere; Augustin Mouinga-Ondéme; Olivier Bourry; Maria Makuwa; Pierre Rouquet; Guido Silvestri; François Simon; Pierre Roques; Cristian Apetrei
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

8.  HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response.

Authors:  Anne Piantadosi; Bhavna Chohan; Dana Panteleeff; Jared M Baeten; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Julie Overbaugh
Journal:  AIDS       Date:  2009-03-13       Impact factor: 4.177

9.  Analysis of the percentage of human immunodeficiency virus type 1 sequences that are hypermutated and markers of disease progression in a longitudinal cohort, including one individual with a partially defective Vif.

Authors:  Anne Piantadosi; Daryl Humes; Bhavna Chohan; R Scott McClelland; Julie Overbaugh
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

10.  The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool.

Authors:  David M Butler; Mary E Pacold; Parris S Jordan; Douglas D Richman; Davey M Smith
Journal:  J Virol Methods       Date:  2009-08-19       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.